Project Grant R03DK145960
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $349,160 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) on September 9, 2025, with completion targeted for June 30, 2028. The award supports a multicenter pilot and feasibility study developing artificial intelligence (AI)-enhanced virtual reality (VR) cognitive behavioral...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $757,885 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded February 1, 2026, with completion by December 31, 2029. The research initiative focuses on identifying and developing therapeutic interventions to prevent the progression of acute kidney injury (AKI) to chronic...
- Summary of Federal Project Grant Award The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded UCLA a $1,089,491 project grant effective March 10, 2025, through February 28, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award funds the development of novel statistical methods, computational algorithms, and user-friendly software tools designed to analyze individual health trajectories and predict disease...
- Federal Project Grant Award Summary The University of California, San Francisco received a $192,215 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded July 15, 2025, with completion scheduled for March 31, 2030. This research initiative will develop and implement a risk communication tool designed to improve treatment persistence with sodium-glucose...
- Federal Project Grant Award Summary Cedars-Sinai Medical Center received a $758,542 project grant awarded July 3, 2025, from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, titled "POP3 Regulates Type I Interferon and Ameliorates Intestinal Inflammation," will be conducted through April 30, 2030, at the institution's California location....
- Federal Grant Award Summary Aurora Health Care, Inc. received a $762,556 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, through June 30, 2030. The award supports development and testing of a novel, semi-automated self-monitoring feedback system designed to enhance weight management interventions in community settings....
- Federal Grant Award Summary Scripps Health received a $165,541 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective September 15, 2025, with completion targeted for July 31, 2030. This K01 career development award supports Dr. San Diego's research to integrate continuous glucose monitoring (CGM) technology into diabetes self-management education...
- Federal Grant Award Summary Wayne State University received a $941,418 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 15, 2025, with completion targeted for August 31, 2028. The grant funds a feasibility study evaluating Mindfulness-Based Stress Reduction delivered through virtual platforms and enhanced with Virtual Reality (MBSR-VR)...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Johns Hopkins University a $806,274 Project Grant on September 10, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The grant supports research on wearable interactive sensory insoles designed to prevent recurrent diabetic foot ulcers (DFU). The project, titled "Wearable Insoles for Recurrent Diabetic Ulcer Prevention"...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded The Regents of the University of California, San Francisco a $737,949 Project Grant on September 24, 2025, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The research project, extending through June 30, 2030, will develop and evaluate modernized clinical methods for assessing fluid excess removal during in-center hemodialysis treatment....
Cedars-Sinai Medical Center received a $125,250 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) awarded February 18, 2026, with completion by January 31, 2028. The grant funds the Movement Over Virtual Reality (MOVR) project, which develops and tests a technology-enabled intervention to increase physical activity among patients with prediabetes. The research addresses the significant public health challenge of physical inactivity and low adherence to Diabetes Prevention Program (DPP) guidelines, particularly in under-resourced communities with limited access to digital health resources. The project delivers two primary products: (1) a digital literacy toolkit and best practices guide for administering health-promoting digital technology and virtual reality (VR) applications in safety-net clinic settings, developed in partnership with community health workers (CHWs); and (2) feasibility study data from a longitudinal single-arm study involving 10 trained CHWs and 20 DPP clinic participants to evaluate whether VR exercise programs can effectively promote physical activity and weight loss in prediabetic populations. The findings will inform the design of a larger randomized controlled trial, generating evidence to support broader implementation of VR technology as a scalable intervention for diabetes prevention in underserved communities.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $125.3k | 2/18/26 |